Are risk factors associated with invasive pneumococcal disease according to different serotypes?

References

• Hausdorff WP, Bryant J, Kloek C, Paradiso PR, Siber GR. The contribution of specific pneumococcal serogroups to different disease manifestations: implications for conjugate vaccine formulation and use, part II. Clin Infect Dis 2000; 30:122 - 40; http://dx.doi.org/10.1086/313609; PMID: 10619741
   PubMed Web of Science ®Google Scholar
• Pilishvili T, Zell ER, Farley MM, Schaffner W, Lynfield R, Nyquist AC, et al. Risk factors for invasive pneumococcal disease in children in the era of conjugate vaccine use. Pediatrics 2010; 126:e9 - 17; http://dx.doi.org/10.1542/peds.2009-2150; PMID: 20547641
   PubMed Web of Science ®Google Scholar
• Levine OS, Farley M, Harrison LH, Lefkowitz L, McGeer A, Schwartz B. Risk factors for invasive pneumococcal disease in children: a population-based case-control study in North America. Pediatrics 1999; 103:E28; http://dx.doi.org/10.1542/peds.103.3.e28; PMID: 10049984
   PubMed Web of Science ®Google Scholar
• Hausdorff WP, Siber G, Paradiso PR. Geographical differences in invasive pneumococcal disease rates and serotype frequency in young children. Lancet 2001; 357:950 - 2; http://dx.doi.org/10.1016/S0140-6736(00)04222-7; PMID: 11289365
   PubMed Web of Science ®Google Scholar
• Brueggemann AB, Griffiths DT, Meats E, Peto T, Crook DW, Spratt BG. Clonal relationships between invasive and carriage Streptococcus pneumoniae and serotype- and clone-specific differences in invasive disease potential. J Infect Dis 2003; 187:1424 - 32; http://dx.doi.org/10.1086/374624; PMID: 12717624
   PubMed Web of Science ®Google Scholar
• Sjöström K, Spindler C, Ortqvist A, Kalin M, Sandgren A, Kühlmann-Berenzon S, et al. Clonal and capsular types decide whether pneumococci will act as a primary or opportunistic pathogen. Clin Infect Dis 2006; 42:451 - 9; http://dx.doi.org/10.1086/499242; PMID: 16421787
   PubMed Web of Science ®Google Scholar
• Picazo J, Ruiz-Contreras J, Casado-Flores J, Giangaspro E, Del Castillo F, Hernández-Sampelayo T, et al, Heracles Study Group. Relationship between serotypes, age, and clinical presentation of invasive pneumococcal disease in Madrid, Spain, after introduction of the 7-valent pneumococcal conjugate vaccine into the vaccination calendar. Clin Vaccine Immunol 2011; 18:89 - 94; http://dx.doi.org/10.1128/CVI.00317-10; PMID: 21047996
   PubMed Web of Science ®Google Scholar
• Martens P, Worm SW, Lundgren B, Konradsen HB, Benfield T. Serotype-specific mortality from invasive Streptococcus pneumoniae disease revisited. BMC Infect Dis 2004; 4:21; http://dx.doi.org/10.1186/1471-2334-4-21; PMID: 15228629
   PubMed Web of Science ®Google Scholar
• Weinberger DM, Harboe ZB, Sanders EAM, Ndiritu M, Klugman KP, Rückinger S, et al. Association of serotype with risk of death due to pneumococcal pneumonia: a meta-analysis. Clin Infect Dis 2010; 51:692 - 9; http://dx.doi.org/10.1086/655828; PMID: 20715907
   PubMed Web of Science ®Google Scholar
• Fenoll A, Granizo JJ, Aguilar L, Giménez MJ, Aragoneses-Fenoll L, Hanquet G, et al. Temporal trends of invasive Streptococcus pneumoniae serotypes and antimicrobial resistance patterns in Spain from 1979 to 2007. J Clin Microbiol 2009; 47:1012 - 20; http://dx.doi.org/10.1128/JCM.01454-08; PMID: 19225097
   PubMed Web of Science ®Google Scholar
• Cohen R, Levy C, Bonnet E, Thollot F, Boucherat M, Fritzell B, et al. Risk factors for serotype 19A carriage after introduction of 7-valent pneumococcal vaccination. BMC Infect Dis 2011; 11:95; http://dx.doi.org/10.1186/1471-2334-11-95; PMID: 21501471
   PubMed Web of Science ®Google Scholar
• Generalitat de Catalunya. Departament de Salut. Manual de vacunacions. Col·leció: Quaderns de salut pública, 14. 4th ed. Direcció General de Salut Pública. Barcelona 2006 Available at; http://www20.gencat.cat/docs/canalsalut/Home%20Canal%20Salut/Professionals/Temes_de_salut/Vacunacions/documents/manualvacunes06.pdf (accessed 14 September 2012).
   Google Scholar
• Domínguez A, Ciruela P, García-García JJ, Moraga F, de Sevilla MF, Selva L, et al. Effectiveness of 7-valent pneumococcal conjugate vaccine in the prevention of invasive pneumococcal disease in children aged 7-59 months. A matched case-control study. Vaccine 2011; 29:9020 - 5; http://dx.doi.org/10.1016/j.vaccine.2011.09.034; PMID: 21939724
   PubMed Web of Science ®Google Scholar
• Kyaw MH, Lynfield R, Schaffner W, Craig AS, Hadler J, Reingold A, et al, Active Bacterial Core Surveillance of the Emerging Infections Program Network. Effect of introduction of the pneumococcal conjugate vaccine on drug-resistant Streptococcus pneumoniae.. N Engl J Med 2006; 354:1455 - 63; http://dx.doi.org/10.1056/NEJMoa051642; PMID: 16598044
   PubMed Web of Science ®Google Scholar
• Whitney CG, Pilishvili T, Farley MM, Schaffner W, Craig AS, Lynfield R, et al. Effectiveness of seven-valent pneumococcal conjugate vaccine against invasive pneumococcal disease: a matched case-control study. Lancet 2006; 368:1495 - 502; http://dx.doi.org/10.1016/S0140-6736(06)69637-2; PMID: 17071283
   PubMed Web of Science ®Google Scholar
• Blanco A, Gimenez F, Asensi F, Bernaola E, de Juan F, García J, et al, Comité Asesor de Vacunas de la Asociación Española de Pediatría. Vaccination schedule of the spanish association of pediatrics: recommendations 2004. An Pediatr (Barc) 2004; 60:468 - 72; PMID: 15105003
   PubMedGoogle Scholar
• Isaacman DJ, McIntosh ED, Reinert RR. Burden of invasive pneumococcal disease and serotype distribution among Streptococcus pneumoniae isolates in young children in Europe: impact of the 7-valent pneumococcal conjugate vaccine and considerations for future conjugate vaccines. Int J Infect Dis 2010; 14:e197 - 209; http://dx.doi.org/10.1016/j.ijid.2009.05.010; PMID: 19700359
   PubMed Web of Science ®Google Scholar
• Aguiar SI, Brito MJ, Gonçalo-Marques J, Melo-Cristino J, Ramirez M. Serotypes 1, 7F and 19A became the leading causes of pediatric invasive pneumococcal infections in Portugal after 7 years of heptavalent conjugate vaccine use. Vaccine 2010; 28:5167 - 73; http://dx.doi.org/10.1016/j.vaccine.2010.06.008; PMID: 20558247
   PubMed Web of Science ®Google Scholar
• Byington CL, Korgenski K, Daly J, Ampofo K, Pavia A, Mason EO. Impact of the pneumococcal conjugate vaccine on pneumococcal parapneumonic empyema. Pediatr Infect Dis J 2006; 25:250 - 4; http://dx.doi.org/10.1097/01.inf.0000202137.37642.ab; PMID: 16511389
   PubMed Web of Science ®Google Scholar
• Selva L, Ciruela P, Esteva C, de Sevilla MF, Codina G, Hernandez S, et al. Serotype 3 is a common serotype causing invasive pneumococcal disease in children less than 5 years old, as identified by real-time PCR. Eur J Clin Microbiol Infect Dis 2012; 31:1487 - 95; http://dx.doi.org/10.1007/s10096-011-1468-7; PMID: 22052607
   PubMed Web of Science ®Google Scholar
• Le Hello S, Watson M, Levy M, Marcon S, Brown M, Yvon JF, et al. Invasive serotype 1 Streptococcus pneumoniae outbreaks in the South Pacific from 2000 to 2007. J Clin Microbiol 2010; 48:2968 - 71; http://dx.doi.org/10.1128/JCM.01615-09; PMID: 20534799
   PubMed Web of Science ®Google Scholar
• Cohen R, Levy C, Bonnet E, Grondin S, Desvignes V, Lecuyer A, et al. Dynamic of pneumococcal nasopharyngeal carriage in children with acute otitis media following PCV7 introduction in France. Vaccine 2010; 28:6114 - 21; http://dx.doi.org/10.1016/j.vaccine.2009.05.037; PMID: 19490958
   PubMed Web of Science ®Google Scholar
• Millar EV, O’Brien KL, Zell ER, Bronsdon MA, Reid R, Santosham M. Nasopharyngeal carriage of Streptococcus pneumoniae in Navajo and White Mountain Apache children before the introduction of pneumococcal conjugate vaccine. Pediatr Infect Dis J 2009; 28:711 - 6; http://dx.doi.org/10.1097/INF.0b013e3181a06303; PMID: 19593248
   PubMed Web of Science ®Google Scholar
• Kaplan SL, Barson WJ, Lin PL, Stovall SH, Bradley JS, Tan TQ, et al. Serotype 19A Is the most common serotype causing invasive pneumococcal infections in children. Pediatrics 2010; 125:429 - 36; http://dx.doi.org/10.1542/peds.2008-1702; PMID: 20176669
   PubMed Web of Science ®Google Scholar
• Singleton RJ, Hennessy TW, Bulkow LR, Hammitt LL, Zulz T, Hurlburt DA, et al. Invasive pneumococcal disease caused by nonvaccine serotypes among alaska native children with high levels of 7-valent pneumococcal conjugate vaccine coverage. JAMA 2007; 297:1784 - 92; http://dx.doi.org/10.1001/jama.297.16.1784; PMID: 17456820
   PubMed Web of Science ®Google Scholar
• Rodríguez MA, González AV, Gavín MA, Martínez FM, Marín NG, Blázquez BR, et al. Invasive pneumococcal disease: association between serotype, clinical presentation and lethality. Vaccine 2011; 29:5740 - 6; http://dx.doi.org/10.1016/j.vaccine.2011.05.099; PMID: 21683112
   PubMed Web of Science ®Google Scholar
• Moore MR, Gertz RE Jr., Woodbury RL, Barkocy-Gallagher GA, Schaffner W, Lexau C, et al. Population snapshot of emergent Streptococcus pneumoniae serotype 19A in the United States, 2005. J Infect Dis 2008; 197:1016 - 27; http://dx.doi.org/10.1086/528996; PMID: 18419539
   PubMed Web of Science ®Google Scholar
• Ampofo K, Bender J, Sheng X, Korgenski K, Daly J, Pavia AT, et al. Seasonal invasive pneumococcal disease in children: role of preceding respiratory viral infection. Pediatrics 2008; 122:229 - 37; http://dx.doi.org/10.1542/peds.2007-3192; PMID: 18676537
   PubMed Web of Science ®Google Scholar
• Kim PE, Musher DM, Glezen WP, Rodriguez-Barradas MC, Nahm WK, Wright CE. Association of invasive pneumococcal disease with season, atmospheric conditions, air pollution, and the isolation of respiratory viruses. Clin Infect Dis 1996; 22:100 - 6; http://dx.doi.org/10.1093/clinids/22.1.100; PMID: 8824973
   PubMed Web of Science ®Google Scholar
• Muñoz-Almagro C, Ciruela P, Esteva C, Marco F, Navarro M, Bartolome R, et al, Catalan study group of invasive pneumococcal disease. Serotypes and clones causing invasive pneumococcal disease before the use of new conjugate vaccines in Catalonia, Spain. J Infect 2011; 63:151 - 62; http://dx.doi.org/10.1016/j.jinf.2011.06.002; PMID: 21679725
   PubMed Web of Science ®Google Scholar
• Hanage WP, Huang SS, Lipsitch M, Bishop CJ, Godoy D, Pelton SI, et al. Diversity and antibiotic resistance among nonvaccine serotypes of Streptococcus pneumoniae carriage isolates in the post-heptavalent conjugate vaccine era. J Infect Dis 2007; 195:347 - 52; http://dx.doi.org/10.1086/510249; PMID: 17205472
   PubMed Web of Science ®Google Scholar
• Smith T, Lehmann D, Montgomery J, Gratten M, Riley ID, Alpers MP. Acquisition and invasiveness of different serotypes of Streptococcus pneumoniae in young children. Epidemiol Infect 1993; 111:27 - 39; http://dx.doi.org/10.1017/S0950268800056648; PMID: 8348930
   PubMed Web of Science ®Google Scholar
• Mothibeli KM, du Plessis M, von Gottberg A, de Gouveia L, Adrian P, Madhi SA, et al, Group for Enteric, Respiratory and Meningeal Disease Surveillance in South Africa (GERMS-SA). An unusual pneumococcal sequence type is the predominant cause of serotype 3 invasive disease in South Africa. J Clin Microbiol 2010; 48:184 - 91; http://dx.doi.org/10.1128/JCM.01011-09; PMID: 19889905
   PubMed Web of Science ®Google Scholar
• Garcia-Vidal C, Ardanuy C, Tubau F, Viasus D, Dorca J, Liñares J, et al. Pneumococcal pneumonia presenting with septic shock: host- and pathogen-related factors and outcomes. Thorax 2010; 65:77 - 81; http://dx.doi.org/10.1136/thx.2009.123612; PMID: 19996337
   PubMed Web of Science ®Google Scholar
• Bender JM, Ampofo K, Korgenski K, Daly J, Pavia AT, Mason EO, et al. Pneumococcal necrotizing pneumonia in Utah: does serotype matter?. Clin Infect Dis 2008; 46:1346 - 52; http://dx.doi.org/10.1086/586747; PMID: 18419434
   PubMed Web of Science ®Google Scholar
• Muñoz-Almagro C, Jordan I, Gene A, Latorre C, García-Garcia JJ, Pallares R. Emergence of invasive pneumococcal disease caused by nonvaccine serotypes in the era of 7-valent conjugate vaccine. Clin Infect Dis 2008; 46:174 - 82; http://dx.doi.org/10.1086/524660; PMID: 18171247
   PubMed Web of Science ®Google Scholar
• Fenoll A, Jado I, Vicioso D, Casal J. Dot blot assay for the serotyping of pneumococci. J Clin Microbiol 1997; 35:764 - 6; PMID: 9041430
   PubMed Web of Science ®Google Scholar
• National Committee for Clinical Laboratory Standards (NCCLS). Performance standards for antimicrobial susceptibility testing: Eighteenth informational supplement. CLSI document M100-S18. ISBN 1-5-56238-653-0. Wayne PA: Clinical and Laboratory Standard Institute 2008.
   Google Scholar
• Office of Population Censuses Surveys. Classification of occupations. HMSO, London 1980.
   Google Scholar